Hara T, Mizuno Y, Nagata M, Okabe Y, Taniguchi S, Harada M, Niho Y, Oshimi K, Ohga S, Yoshikai Y
Department of Pediatrics, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Blood. 1990 Feb 15;75(4):941-50.
The gamma delta T-cell receptor-positive (gamma delta TCR+) lymphocytes were markedly expanded up to 68% of peripheral blood lymphocytes in a case with type I autoimmune polyglandular syndrome and pure red blood cell aplasia (PRCA). The gamma delta TCR+ cells showed CD4 negative, 16% dim-CD8 positive and 10% to 46% human leukocyte antigen-D-related (HLA-DR) positive, and exhibited no monoclonality as assessed by the patterns of TCR gene rearrangements. Functional studies revealed that the proliferative responses of the patient's peripheral blood mononuclear cells (PBMC) were severely depressed to candida antigen, alloantigens, and autoantigens (non-T cells). The gamma delta TCR+ cells had no suppressive effect on the proliferative response of the alpha beta TCR+ cells to candida. The patient's PBMC, isolated gamma delta TCR+ cells but not alpha beta TCR+ cells, exhibited non-major histocompatibility complex (MHC)-restricted cytotoxicity. Furthermore, the patient's PBMC and isolated gamma delta TCR+ cells inhibited burst-forming units-erythroid (BFU-E), but not colony-forming units/granulocyte-macrophage (CFU-GM). Supernatants derived from the patient's T cells similarly inhibited BFU-E but not CFU-GM. The clinical course of the patient also showed a close correlation between the decreased number of total lymphocyte counts, especially HLA-DR + gamma delta TCR+ cell counts, and recovery from PRCA. These observations suggest that the gamma delta TCR+ cells might be functional in vivo and involved in the pathogenesis of PRCA in this patient.
在一例患有I型自身免疫性多腺体综合征和纯红细胞再生障碍性贫血(PRCA)的患者中,γδT细胞受体阳性(γδTCR+)淋巴细胞显著扩增,占外周血淋巴细胞的68%。γδTCR+细胞显示CD4阴性,16%为低表达CD8阳性,10%至46%的人类白细胞抗原-D相关(HLA-DR)阳性,并且通过TCR基因重排模式评估显示无单克隆性。功能研究表明,患者外周血单个核细胞(PBMC)对念珠菌抗原、同种异体抗原和自身抗原(非T细胞)的增殖反应严重受损。γδTCR+细胞对αβTCR+细胞对念珠菌的增殖反应没有抑制作用。患者的PBMC、分离出的γδTCR+细胞而非αβTCR+细胞表现出非主要组织相容性复合体(MHC)限制的细胞毒性。此外,患者的PBMC和分离出的γδTCR+细胞抑制红系爆式集落形成单位(BFU-E),但不抑制粒-巨噬细胞集落形成单位(CFU-GM)。来自患者T细胞的上清液同样抑制BFU-E但不抑制CFU-GM。患者的临床病程还显示,总淋巴细胞计数减少,尤其是HLA-DR+γδTCR+细胞计数减少与PRCA的恢复之间存在密切相关性。这些观察结果表明,γδTCR+细胞可能在体内发挥作用,并参与了该患者PRCA的发病机制。